A formalization of one of the main claims of "Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention" by Fragoulakis et al. 20191

George P. Patrinos. A formalization of one of the main claims of "Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention" by Fragoulakis et al. 20191. Data Sci., 5(1):29-33, 2022. [doi]

Abstract

Abstract is missing.